Últimas noticias sobre Surgepays (NASDAQ:SURG) Bolsa

Surgepays

Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; Lead Generation is a generation and case management solutions company serving law firms in the mass tort industry; and Others. It generates the revenue from Mobile Virtual Network Operator segment.

Surgepays Inc

SURGLINE INTL INC by SurgLine International, Inc.

SurgLine International Inc

Surgalign Holdings Inc

SURGE BATTERY METALS INC by Surge Battery Metals Inc.

Surge Battery Metals Inc

SURGE COMPONENTS INC by Surge Components, Inc.

Surge Components Inc

Surge Copper Corp

Surge Energy Inc

SURGE TECHS INC by Surge Technologies, Inc.

Surge Technologies Inc

Surgery Partners Inc

SURGICAL SCINCE SWEDN NEW by Surgical Science Sweden AB

Surgical Science Sweden AB

<h3>Gainers</h3>
<ul>
<li>Direct Digital Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRCT#NASDAQ">DRCT</a>) stock increased by 22.1% to $2.92 during Friday's regular session. The company's market cap stands at $41.8 million. </li>
<li>Surgepays (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SURG#NASDAQ">SURG</a>) stock rose 15.08% to $2.06. The market value of their outstanding shares is at $40.6 million. </li>
<li>Able View Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABLV#NASDAQ">ABLV</a>) shares increased by 10.46% to $0.95. The company's market cap stands at $39.7 million. </li>
<li>Oriental Culture Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCG#NASDAQ">OCG</a>) shares rose 10.34% to $1.28. The company's market cap stands at $5.8 million. </li>
<li>Sify Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIFY#NASDAQ">SIFY</a>) shares rose 8.97% to $3.28. The company's market cap stands at $1.4 billion. </li>
<li>Lee Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEE#NASDAQ">LEE</a>) stock increased by 8.95% to $15.31. The company's market cap stands at $94.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>John Wiley &amp; Sons (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLYB#NYSE">WLYB</a>) shares declined by 21.1% to $38.95 during Friday's regular session. The market value of their outstanding shares is at $2.1 billion. </li>
<li>Hanryu Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRYU#NASDAQ">HRYU</a>) stock decreased by 10.73% to $0.21. The market value of their outstanding shares is at $11.0 million. </li>
<li>ZW Data Action Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNET#NASDAQ">CNET</a>) stock decreased by 9.5% to $2.06. The market value of their outstanding shares is at $3.7 million. </li>
<li>Reading Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDIB#NASDAQ">RDIB</a>) stock declined by 9.21% to $6.61. The company's market cap stands at $148.2 million. </li>
<li>Global Mofy AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GMM#NASDAQ">GMM</a>) shares fell 8.64% to $0.53. The market value of their outstanding shares is at $15.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-communication-services-stocks/" title="www.benzinga.com/money/best-communication-services-stocks/">www.benzinga.com/money/best-communication-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

ABLV

CNET

DRCT

HRYU

RDIB

SIFY

SURG

WLYB

11 Communication Services Stocks Moving In Friday's Intraday Session

Existing ACP Customers Can Now Opt-in to Lifeline Program
BARTLETT, Tenn., Oct. 10, 2024 /PRNewswire/ -- SurgePays, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SURG#NASDAQ">SURG</a>) ("SurgePays" or the "Company"), a technology and telecom company announced today that it has signed a Master Services Agreement (MSA) with TerraCom, Inc. ("TerraCom"), a wireless service provider and licensed Lifeline provider, effective October 3, 2024.&nbsp; SurgePays and TerraCom have agreed to finalize a stock purchase agreement to acquire the majority of TerraCom stock, subject to regulatory approval.&nbsp;&nbsp;

News

SurgePays Announces Master Services Agreement With TerraCom, Inc., Effective October 3, 2024

Ascendiant Capital analyst Edward Woo maintains Surgepays (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SURG#NASDAQ">SURG</a>) with a Buy and lowers the price target from $9.5 to $9.

Price Target

Analyst Ratings

Ascendiant Capital Maintains Buy on Surgepays, Lowers Price Target to $9

SurgePays, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SURG#NASDAQ">SURG</a>) ("SurgePays" or the "Company"), a technology and telecom company focused on the underbanked and underserved communities, announces today that it is commencing its previously authorized stock repurchase program of up to $5 million in SurgePays' common stock.

Buybacks

SurgePays Commences Its Previously Authorized Stock Repurchase Program Of Up To $5M In Common Stock

WIIM

SurgePays shares are trading lower after the company reported worse-than-expected Q2 sales results.

SurgePays shares are trading lower after the company reported a year-over-year decrease in Q2 EPS results and worse-than-expected Q2 sales results.

SurgePays Authorizes $5M Share Repurchase

Surgepays (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SURG#NASDAQ">SURG</a>) reported quarterly losses of $(0.66) per share. This is a 265 percent decrease over earnings of $0.40 per share from the same period last year. The company reported quarterly sales of $15.086 million which missed the analyst consensus estimate of $15.154 million by 0.45 percent. This is a 57.96 percent decrease over sales of $35.886 million the same period last year.

Earnings

Earnings Misses

Surgepays Q2 2024 GAAP EPS $(0.66) Down From $0.40 YoY, Sales $15.086M Miss $15.154M Estimate

SurgePays, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/surg#NASDAQ">SURG</a>) is set to report second-quarter 2024 results on Aug 13.
The Zacks Consensus Estimate for revenues is currently pegged at $23.35 million, suggesting a decrease of 34.94% from the figure reported in the year-ago quarter.
The consensus mark for loss per share has remained unchanged at 6 cents in the past 30 days, indicating a decline of 115% from the year-ago quarter&#39;s reported figure.
Let&#39;s see how things have shaped up for this announcement.
<div class="chart_embed">
<h3>SurgePays, Inc. Price and EPS Surprise</h3>
<img alt="SurgePays, Inc. Price and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/72/1723467576.png" style="height:311px; width:620px" title="" />
SurgePays, Inc. price-eps-surprise | SurgePays, Inc. Quote
</div>
<h3>Factors to Note</h3>
SURG&#39;s second-quarter results are expected to be hurt by operational changes by management to shift the company&#39;s focus away from the non-core business Lead Generation&#39;s subsidiary LogicsIQ.
At the end of the first quarter, Comprehensive Platform Services reported revenues of $2.53 million, representing a 13.7% decline from the prior quarter. This trend is expected to have continued in the to-be-reported quarter.
In the first quarter, the company launched the LinkUp Mobile website, www. linkupmobile.com, and is well underway in the national rollout. This is likely to have aided the top-line growth in the second quarter.
In the first quarter, the company acquired the software development and point-of-sale equipment and operations of DNR Business Solutions Inc. d/b/a ClearLine Mobile. Goodwill was $4.16 million as of Mar 31, 2024, and $1.6 million as of Dec 31, 2023.
This acquisition is likely to have expanded SurgePays&#39; customer base and enhanced its product offerings, creating new revenue opportunities. It is also expected to have generated operational efficiencies and strengthened SURG&#39;s competitive position in the to-be-reported quarter.
<h3>What Our Model Indicates</h3>
According to the Zacks model, the combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that&#39;s not the case here.
SURG has an Earnings ESP of 0.00% and a Zacks Rank of 3 at present.
<h3>Stocks With the Favorable Combination</h3>
Here are some stocks that, according to our model, have the right combination of elements to beat on earnings this season.
Brinker International (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eat#NYSE">EAT</a>) has an Earnings ESP of +6.40% and sports a Zacks Rank #1 at present.
Brinker International is set to report fourth-quarter fiscal 2024 results on Aug 14. The Zacks Consensus Estimate for EAT&#39;s earnings is pegged at $1.65 per share, indicating growth of 18.7% from the year-ago quarter&#39;s reported figure.
Abercrombie &amp; Fitch (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/anf#NYSE">ANF</a>) has an Earnings ESP of +5.40% and sports a Zacks Rank #1 at present.
Abercrombie &amp; Fitch is slated to report its second-quarter 2024 results on Aug 28. The Zacks Consensus Estimate for ANF&#39;s earnings is pegged at $2.13 per share, indicating a significant jump of 93.64% from the prior-year quarter&#39;s reported figure.
Affirm (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/afrm#NASDAQ">AFRM</a>) has an Earnings ESP of +19.64% and a Zacks Rank #2 at present.
Affirm is scheduled to release fourth-quarter fiscal 2024 results on Aug 28. The Zacks Consensus Estimate for AFRM&#39;s loss is pegged at 45 cents per share, indicating a significant jump of 34.78% from the prior-year quarter&#39;s reported figure.
<a href="https://www.zacks.com/stock/news/2320759/surgepays-surg-to-report-q2-earnings-what-s-in-the-cards?cid=CS-BENZ-FT-analyst_blog|earnings_preview-2320759">To read this article on Zacks.com click here.</a>

Mid Cap

Penny Stocks

Small Cap

Markets

Trading Ideas

AFRM

SurgePays to Report Q2 Earnings: What's in the Cards?

SurgePays Announces ClearLine's Launch Of POS Marketing Solution Integrated With Clover And PAX Devices; To Debut At RSPA RetailNOW Conference In Las Vegas

Anthony Evers, Chief Financial Officer at Surgepays (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SURG#NASDAQ">SURG</a>), disclosed an insider sell on July 3, according to a recent SEC filing.
What Happened: According to a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001392694/000149315224026258//Archives/edgar/data/1392694/000149315224026258/0001493152-24-026258-index.htm">U.S. Securities and Exchange Commission</a> on Wednesday, Evers sold 36,667 shares of Surgepays. The total transaction value is $110,323.
During Thursday's morning session, Surgepays shares down by 5.45%, currently priced at $2.95.
<h3>Discovering Surgepays: A Closer Look</h3>
Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; Lead Generation is a generation and case management solutions company serving law firms in the mass tort industry; and Others. It generates the revenue from Mobile Virtual Network Operator segment.
<h3>Unraveling the Financial Story of Surgepays</h3>
Decline in Revenue: Over the 3 months period, Surgepays faced challenges, resulting in a decline of approximately -9.63% in revenue growth as of 31 March, 2024. This signifies a reduction in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Communication Services sector.
Key Insights into Profitability Metrics:
<ul>
<li>
Gross Margin: With a low gross margin of 26.04%, the company exhibits below-average profitability, signaling potential struggles in cost efficiency compared to its industry peers.
</li>
<li>
Earnings per Share (EPS): Surgepays's EPS is below the industry average, signaling challenges in bottom-line performance with a current EPS of 0.07.
</li>
</ul>
Debt Management: Surgepays's debt-to-equity ratio is below the industry average. With a ratio of 0.1, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
Analyzing Market Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: The Price to Earnings ratio of 2.74 is lower than the industry average, indicating potential undervaluation for the stock.
</li>
<li>
Price to Sales (P/S) Ratio: The P/S ratio of 0.37 is lower than the industry average, implying a discounted valuation for Surgepays's stock in relation to sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With an EV/EBITDA ratio lower than industry averages at 1.36, Surgepays could be considered undervalued.
</li>
</ul>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Understanding the Significance of Insider Transactions</h3>
While insider transactions provide valuable information, they should be part of a broader analysis in making investment decisions.
When discussing legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated in Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are required to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.
A new purchase by a company insider is a indication that they anticipate the stock will rise.
On the other hand, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
<h3>Navigating the World of Insider Transaction Codes</h3>
<a href="https://www.benzinga.com/money/investing-tools">Investors</a> prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates grant, award or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001392694">Check Out The Full List Of Surgepays's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Insider Transaction: Anthony Evers Sells $110K Worth Of Surgepays Shares

Rapid7 (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rpd#NASDAQ">RPD</a>) shares rallied 6.8% in the last trading session to close at $40.55. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock&#39;s 0.7% gain over the past four weeks.
The upswing came after The Wall Street Journal reported that the activist investor, Jana Partners, has built a stake in Rapid7 and is pushing the cybersecurity company to sell itself. Citing sources familiar with the matter, the news agency revealed that apart from urging for a sale, Jana Partners is also pushing Rapid7 to improve operations.
This cybersecurity company is expected to post quarterly earnings of $0.52 per share in its upcoming report, which represents a year-over-year change of +188.9%. Revenues are expected to be $204.06 million, up 7.2% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For Rapid7, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock&#39;s price usually doesn&#39;t keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on RPD going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold).
Rapid7 is a member of the Zacks Internet - Software industry. One other stock in the same industry, SurgePays, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/surg#NASDAQ">SURG</a>), finished the last trading session 3.2% higher at $3.23. SURG has returned -18.3% over the past month.
SurgePays, Inc.&#39;s consensus EPS estimate for the upcoming report has remained unchanged over the past month at -$0.06. Compared to the company&#39;s year-ago EPS, this represents a change of -115%. SurgePays, Inc. currently boasts a Zacks Rank of #4 (Sell).
<a href="https://www.zacks.com/stock/news/2294123/rapid7-rpd-surges-6-8-is-this-an-indication-of-further-gains?cid=CS-BENZ-FT-tale_of_the_tape|daily_price_change_5%-2294123">To read this article on Zacks.com click here.</a>

Tech

Rapid7 Surges 6.8%: Is This an Indication of Further Gains?

Ascendiant Capital analyst Edward Woo maintains Surgepays (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SURG#NASDAQ">SURG</a>) with a Buy and lowers the price target from $10 to $9.5.

Ascendiant Capital Maintains Buy on Surgepays, Lowers Price Target to $9.5

<h3>Gainers</h3>
<ul>
<li>AMC Enter Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMC#NYSE">AMC</a>) shares moved upwards by 10.5% to $5.74 during Monday's after-market session. The company's market cap stands at $1.6 billion. As per the news, the Q1 earnings report came out 3 days ago. </li>
<li>Surgepays (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SURG#NASDAQ">SURG</a>) shares moved upwards by 7.95% to $4.07. The company's market cap stands at $78.4 million. As per the news, the Q1 earnings report came out today. </li>
<li>BuzzFeed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZFD#NASDAQ">BZFD</a>) shares moved upwards by 6.12% to $2.25. The market value of their outstanding shares is at $82.3 million. As per the news, the Q1 earnings report came out today. </li>
<li>Eventbrite (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EB#NYSE">EB</a>) stock moved upwards by 4.59% to $5.69. The market value of their outstanding shares is at $552.5 million. </li>
<li>Golden Matrix Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GMGI#NASDAQ">GMGI</a>) stock rose 3.39% to $5.48. The company's market cap stands at $651.4 million. </li>
<li>Altice USA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATUS#NYSE">ATUS</a>) stock moved upwards by 3.33% to $2.17. The company's market cap stands at $998.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Antelope Ent Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHL#NASDAQ">AEHL</a>) stock declined by 7.2% to $1.43 during Monday's after-market session. The company's market cap stands at $9.5 million. As per the news, the FY earnings report came out yesterday. </li>
<li>Cineverse (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNVS#NASDAQ">CNVS</a>) stock declined by 5.0% to $0.88. The company's market cap stands at $11.7 million. </li>
<li>Integral Ad Science (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IAS#NASDAQ">IAS</a>) stock fell 4.67% to $9.26. The market value of their outstanding shares is at $1.4 billion. As per the news, the Q1 earnings report came out 2 days ago. </li>
<li>Global Mofy Metaverse (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GMM#NASDAQ">GMM</a>) shares decreased by 2.06% to $0.95. The company's market cap stands at $27.1 million. </li>
<li>AMC Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMCX#NASDAQ">AMCX</a>) shares fell 1.97% to $14.93. The market value of their outstanding shares is at $657.5 million. The company's, Q1 earnings came out yesterday. </li>
<li>Chicken Soup for the Soul (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSSE#NASDAQ">CSSE</a>) stock decreased by 1.7% to $0.29. The company's market cap stands at $9.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-communication-services-stocks/" title="www.benzinga.com/money/best-communication-services-stocks/">www.benzinga.com/money/best-communication-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AEHL

AMCX

ATUS

BZFD

CNVS

CSSE

GMGI

12 Communication Services Stocks Moving In Monday's After-Market Session

Surgepays (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SURG#NASDAQ">SURG</a>) reported quarterly earnings of $0.07 per share which missed the analyst consensus estimate of $0.20 by 65 percent. The company reported quarterly sales of $31.429 million which beat the analyst consensus estimate of $29.907 million by 5.09 percent. This is a 9.62 percent decrease over sales of $34.776 million the same period last year.

Earnings Beats

Surgepays Q1 2024 Adj EPS $0.07 Misses $0.20 Estimate, Sales $31.429M Beat $29.907M Estimate

Ascendiant Capital analyst Edward Woo maintains Surgepays (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SURG#NASDAQ">SURG</a>) with a Buy and lowers the price target from $11.5 to $10.

Ascendiant Capital Maintains Buy on Surgepays, Lowers Price Target to $10

Shares of Clover Health Investments, Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clov#NASDAQ">CLOV</a>) rose sharply during Wednesday&rsquo;s session after the company reported better-than-expected fourth-quarter revenue results and issued FY24 insurance revenue guidance.
Clover Health Investments reported quarterly sales of $510.3 million which beat the analyst consensus estimate of $480.25 million by 6.26% and represents a 43.22% decrease over sales of $898.79 million the same period last year.
Clover Health Investments shares climbed 11.2% to $0.8537 on Wednesday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Gaxos.ai Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gxai#NASDAQ">GXAI</a>) shares jumped 128.9% to $12.18 after the company announced it acquired the rights to use certain AI-enabled technology from Ultiself.</li>
<li>Veritone, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/veri#NASDAQ">VERI</a>) gained 52.4% to $2.6076 following strong sales results.</li>
<li>NuCana plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ncna#NASDAQ">NCNA</a>) gained 50.2% to $0.5869 after the company was granted a US Patent for &quot;Phosphoramidate Derivatives For Use In The Treatment Of Cancer; Especially In The Treatment Where The Patient Shows Resistance.&quot;</li>
<li>The Beauty Health Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/skin#NASDAQ">SKIN</a>) rose 31.9% to $4.7350 after the company reported better-than-expected fourth-quarter revenue results.</li>
<li>Arq, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arq#NASDAQ">ARQ</a>) gained 28.3% to $4.4522 after the company reported upbeat fourth-quarter results.</li>
<li>MicroCloud Hologram Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/holo#NASDAQ">HOLO</a>) jumped 26.6% to $6.19.</li>
<li>Kintara Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ktra#NASDAQ">KTRA</a>) shares gained 26.2% to $0.1055.</li>
<li>Nature&#39;s Sunshine Products, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/natr#NASDAQ">NATR</a>) jumped 24.7% to $21.47 after the company reported better-than-expected fourth-quarter adjusted EPS results and issued FY24 net sales guidance.</li>
<li>Heron Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hrtx#NASDAQ">HRTX</a>) gained 24.7% to $2.9428 after the company reported better-than-expected fourth-quarter adjusted EPS results and issued FY24 revenue guidance. Also, Needham maintained a Buy rating on the stock and raised its price target from $4 to $5.</li>
<li>Li-Cycle Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/licy#NASDAQ">LICY</a>) shares gained 23.2% to $0.7233. Li-Cycle shares jumped 46% on Tuesday after the company entered an agreement to issue a senior secured convertible note in an aggregate principal amount of $75 million to an affiliate of Glencore.</li>
<li>Cue Biopharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cue#NASDAQ">CUE</a>) gained 19.2% to $2.11 after Jefferies initiated coverage on the stock with a Buy rating and $6 price target.</li>
<li>AdTheorent Holding Company, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adth#NASDAQ">ADTH</a>) surged 19% to $3.4150 following strong sales.</li>
<li>SIGA Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/siga#NASDAQ">SIGA</a>) gained 18.8% to $6.32 after the company reported a year-over-year increase in quarterly financial results.</li>
<li>Educational Development Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/educ#NASDAQ">EDUC</a>) surged 18.1% to $2.0432.</li>
<li>Portage Biotech Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prtg#NASDAQ">PRTG</a>) gained 17.7% to $0.6589.</li>
<li>Williams-Sonoma, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wsm#NYSE">WSM</a>) climbed 17.7% to $283.70 after the company reported better-than-expected fourth-quarter earnings, announced a new $ 1 billion stock repurchase authorization and increased its quarterly dividend.</li>
<li>HUTCHMED (China) Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hcm#NASDAQ">HCM</a>) shares climbed 15.8% to $18.91 after gaining 9% on Tuesday.</li>
<li>Annexon, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/annx#NASDAQ">ANNX</a>) rose 15% to $5.28. Needham analyst Joseph Stringer reiterated Annexon with a Buy and maintained a $16 price target.</li>
<li>Mind Medicine (MindMed) Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnmd#NASDAQ">MNMD</a>) gained 13.2% to $8.90.</li>
<li>Full Truck Alliance Co. Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ymm#NYSE">YMM</a>) climbed 11.2% to $7.74. Full Truck Alliance announced extension of share repurchase program up to $300 million.</li>
<li>Summit Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smmt#NASDAQ">SMMT</a>) gained 10% to $4.7450.</li>
<li>Qilian International Holding Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qli#NASDAQ">QLI</a>) climbed 10% to $0.6052.</li>
<li>PBF Energy Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pbf#NYSE">PBF</a>) gained 9.4% to $55.18.</li>
<li>BeiGene, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bgne#NASDAQ">BGNE</a>) shares climbed 9% to $178.44.</li>
<li>Minim, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/minm#NASDAQ">MINM</a>) gained 8.3% to $5.43 after the company announced that it entered into a definitive merger agreement with e2Companies.</li>
<li>Recursion Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rxrx#NASDAQ">RXRX</a>) rose 7% to $ 11.27.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>voxeljet AG (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vjet#NASDAQ">VJET</a>) shares fell 40.8% to $0.5922 after the company announced it will voluntarily delist its ADSs from Nasdaq and deregister its ADSs. The company also announced the restatement and extension of its loan financing with Anzu.</li>
<li>Luna Innovations Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/luna#NASDAQ">LUNA</a>) fell 39% to $3.82 after the company announced that it will delay the release of its fourth-quarter and FY23 financial results. and said financial statements for the quarters ended Jun. 30 and Sept. 30 should no longer be relied upon.</li>
<li>SurgePays, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/surg#NASDAQ">SURG</a>) fell 30.5% to $4.86 after the company reported worse-than-expected fourth-quarter financial results.</li>
<li>P3 Health Partners Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/piii#NASDAQ">PIII</a>) fell 29.4% to $0.72.</li>
<li>SOS Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sos#NYSE">SOS</a>) dipped 28% to $1.5399 G</li>
<li>Allbirds, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bird#NASDAQ">BIRD</a>) declined 25.3% to $0.6952 after the company reported worse-than-expected fourth-quarter GAAP EPS results.</li>
<li>Fangdd Network Group Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/duo#NASDAQ">DUO</a>) fell 23.3% to $0.5710.</li>
<li>WideOpenWest, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wow#NYSE">WOW</a>) fell 21.1% to $2.7290 after the company reported worse-than-expected fourth-quarter financial results and issued guidance.</li>
<li>NaaS Technology Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/naas#NASDAQ">NAAS</a>) fell 20.1% to $1.19 after the company announced a $6 million registered direct offering.</li>
<li>Comtech Telecommunications Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmtl#NASDAQ">CMTL</a>) fell 19% to $4.6599. Comtech named John Ratigan as Interim Chief Executive Officer.</li>
<li>Aterian, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ater#NASDAQ">ATER</a>) tumbled 19% to $0.3783 following quarterly results.</li>
<li>Psyence Biomedical Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pbm#NASDAQ">PBM</a>) fell 17.8% to $1.01.</li>
<li>reAlpha Tech Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aire#NASDAQ">AIRE</a>) fell 16.3% to $1.07 after the company reported EPS for the eight months ended Dec. 31, 2023.</li>
<li>loanDepot, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ldi#NYSE">LDI</a>) fell 15.9% to $2.1350 following weak quarterly results.</li>
<li>Bit Origin Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/btog#NASDAQ">BTOG</a>) fell 15.7% to $4.45 after gaining 11% on Tuesday.</li>
<li>Dollar Tree, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dltr#NASDAQ">DLTR</a>) declined 14.5% to $128.00 after the company reported worse-than-expected fourth-quarter financial results and issued first-quarter EPS guidance below estimates.</li>
<li>Rackspace Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rxt#NASDAQ">RXT</a>) dipped 13.3% to $1.9150 after the company issued first-quarter guidance below estimates. The company also announced refinancing transactions.</li>
<li>ZIM Integrated Shipping Services Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/zim#NYSE">ZIM</a>) fell 12.4% to $10.22 following weak quarterly sales.</li>
<li>Neumora Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nmra#NASDAQ">NMRA</a>) declined 12.2% to $15.24.</li>
<li>ECD Automotive Design, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ecda#NASDAQ">ECDA</a>) dipped 10.8% to $1.07 after jumping over 13% on Tuesday.</li>
<li>Solowin Holdings (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/swin#NASDAQ">SWIN</a>) fell 8.6% to $26.61.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/24/03/37657561/nvidia-to-rally-around-20-here-are-10-top-analyst-forecasts-for-wednesday"> NVIDIA To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday </a>

Intraday Update

ADTH

AIRE

ANNX

ATER

BGNE

BIRD

BTOG

CLOV

CMTL

DLTR

ECDA

EDUC

GXAI

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

HRTX

Kintara Therapeutics, Inc. - Common Stock

KTRA

LICY

LUNA

MINM

MNMD

NAAS

NATR

NCNA

NMRA

PIII

PRTG

RXRX

SIGA

SKIN

SMMT

SWIN

VERI

VJET

Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Maxim Group analyst Michael Diana downgrades Surgepays (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SURG#NASDAQ">SURG</a>) from Buy to Hold.

Downgrades

Maxim Group Downgrades Surgepays to Hold

U.S. stocks traded mixed this morning, with the Nasdaq Composite falling around 50 points on Wednesday.
Following the market opening Wednesday, the Dow traded up 0.08% to 39,037.74 while the NASDAQ fell 0.37% to 16,206.04. The S&amp;P 500 also rose, gaining, 0.11% to 5,169.68.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/03/37656462/top-4-tech-and-telecom-stocks-that-may-explode-this-month"> Top 4 Tech And Telecom Stocks That May Explode This Month </a>
&nbsp;
<h3>Leading and Lagging Sectors</h3>
&nbsp;
Energy shares jumped by 1.6% on Wednesday.
In trading on Wednesday, information technology shares fell by 0.9%.
&nbsp;
<h3>Top Headline</h3>
&nbsp;
Williams-Sonoma, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wsm#NYSE">WSM</a>) posted better-than-expected earnings for its fourth quarter on Wednesday.
Williams-Sonoma posted quarterly earnings of $5.44 per share, beating market estimates of $5.12 per share. The company&rsquo;s quarterly sales came in at $2.28 billion versus expectations of $2.23 billion.
The company announced a new $ 1 billion stock repurchase authorization and increased its quarterly dividend.
&nbsp;
<h3>Equities Trading UP</h3>
&nbsp;
Gaxos.ai Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gxai#NASDAQ">GXAI</a>) shares shot up 129% to $12.19 after the company announced it acquired the rights to use certain AI-enabled technology from Ultiself.
Shares of NuCana plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ncna#NASDAQ">NCNA</a>) got a boost, surging 61% to $0.6276 after the company was granted a US Patent for &quot;Phosphoramidate Derivatives For Use In The Treatment Of Cancer; Especially In The Treatment Where The Patient Shows Resistance.&quot;
Kintara Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ktra#NASDAQ">KTRA</a>) shares were also up, gaining 54% to $0.1285.
&nbsp;
<h3>Equities Trading DOWN</h3>
&nbsp;
voxeljet AG (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vjet#NASDAQ">VJET</a>) shares dropped 40% to $0.60 after the company announced it will voluntarily delist its ADSs from Nasdaq and deregister its ADSs. The company also announced the restatement and extension of its loan financing with Anzu.
Shares of SurgePays, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/surg#NASDAQ">SURG</a>) were down 32% to $4.7589 after the company reported worse-than-expected fourth-quarter financial results.
Luna Innovations Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/luna#NASDAQ">LUNA</a>) was down, falling 34% to $4.16 after the company announced that it will delay the release of its fourth-quarter and FY23 financial results. and said financial statements for the quarters ended Jun. 30 and Sept. 30 should no longer be relied upon.
Also Check This Out:<a href="https://www.benzinga.com/news/24/03/37657561/nvidia-to-rally-around-20-here-are-10-top-analyst-forecasts-for-wednesday"> NVIDIA To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday </a>
&nbsp;
<h3>Commodities</h3>
&nbsp;
In commodity news, oil traded up 1.5% to $78.71 while gold traded up 0.1% at $2,168.70.
Silver traded up 0.5% to $24.525 on Wednesday while copper rose 1.8% to $4.0030.
&nbsp;
<h3>Euro zone</h3>
&nbsp;
European shares were higher today. The eurozone&rsquo;s STOXX 600 rose 0.2%, London&rsquo;s FTSE 100 rose 0.1% while Spain&rsquo;s IBEX 35 Index rose 1.5% The German DAX rose 0.1% French CAC 40 rose 0.6% while Italy&rsquo;s FTSE MIB Index gained 0.6%.
Industrial production in the Eurozone declined by 3.2% month-over-month in January versus a revised 1.6% increase in December.
The UK&#39;s trade deficit increased to &pound;3.129 billion in January from &pound;2.603 billion in the previous month. Industrial production in the UK declined 0.2% month-over-month for January. The British economy grew by 0.2% month-over-month in January compared to a 0.1% decline in December.
&nbsp;
<h3>Asia Pacific Markets</h3>
&nbsp;
Asian markets closed lower on Wednesday, with Japan&rsquo;s Nikkei 225 falling 0.26%, Hong Kong&rsquo;s Hang Seng Index falling 0.07%, China&rsquo;s Shanghai Composite Index falling 0.40% and India&rsquo;s S&amp;P BSE Sensex dipping 1.23%.
&nbsp;
<h3>Economics</h3>
&nbsp;
U.S. mortgage applications rose by 7.1% in the week ending March 8, versus a 9.7% increase in the prior period.

Now Read This: <a href="https://www.benzinga.com/news/24/03/37656606/hp-cisco-and-2-other-stocks-insiders-are-selling"> HP, Cisco And 2 Other Stocks Insiders Are Selling </a>
&nbsp;

Eurozone

Commodities

Global

US Stocks Mixed; Williams-Sonoma Earnings Top Views

Shares of SurgePays, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/surg#NASDAQ">SURG</a>) fell sharply in today&rsquo;s pre-market trading after the company reported worse-than-expected <a href="https://www.benzinga.com/quote/SURG/earnings">fourth-quarter financial results</a>.
Surgepays posted GAAP earnings of 19 cents per share, missing market estimates of 41 cents per share. The company&rsquo;s quarterly sales came in at $32.318 million versus expectations of $33.521 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
SurgePays shares dipped 14.6% to $5.97 in pre-market trading
Here are some other stocks moving in pre-market trading.
<h3>Gainers</h3>
<ul>
<li>NuCana plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ncna#NASDAQ">NCNA</a>) gained 99.6% to $0.7806 in pre-market trading after the company was granted U.S. Patent #11925658 for &quot;Phosphoramidate Derivatives For Use In The Treatment Of Cancer; Especially In The Treatment Where The Patient Shows Resistance&quot;</li>
<li>ShiftPixy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pixy#NASDAQ">PIXY</a>) shares rose 50% to $4.71 in pre-market trading after dipping over 19% on Tuesday.</li>
<li>Tenon Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tnon#NASDAQ">TNON</a>) rose 48.2% to $2.15 in pre-market trading after the company reported better-than-expected fourth-quarter GAAP EPS results.</li>
<li>Minim, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/minm#NASDAQ">MINM</a>) gained 39.8% to $7.01 in pre-market trading after the company announced that it entered into a definitive merger agreement with e2Companies.</li>
<li>Qilian International Holding Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qli#NASDAQ">QLI</a>) climbed 21.1% to $0.6665 in pre-market trading.</li>
<li>Benson Hill, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bhil#NYSE">BHIL</a>) shares gained 20% to $0.2280 in pre-market trading.</li>
<li>The Beauty Health Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/skin#NASDAQ">SKIN</a>) rose 17.3% to $4.21 in pre-market trading after the company reported better-than-expected fourth-quarter revenue results.</li>
<li>Li-Cycle Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/licy#NASDAQ">LICY</a>) shares gained 15.8% to $0.68 in pre-market trading. Li-Cycle shares jumped 46% on Tuesday after the company entered an agreement to issue a senior secured convertible note in an aggregate principal amount of $75 million to an affiliate of Glencore.</li>
<li>HUTCHMED (China) Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hcm#NASDAQ">HCM</a>) shares climbed 15% to $18.78 in pre-market trading after gaining 9% on Tuesday.</li>
<li>Arq, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arq#NASDAQ">ARQ</a>) gained 14.3% to $3.97 in pre-market trading after the company reported upbeat fourth-quarter results.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Aeva Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aeva#NASDAQ">AEVA</a>) fell 20.6% to $0.8735 pre-market trading after dipping around 15% on Tuesday.</li>
<li>Bit Origin Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/btog#NASDAQ">BTOG</a>) fell 16.1% to $4.43 in pre-market trading after gaining 11% on Tuesday.</li>
<li>ECD Automotive Design, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ecda#NASDAQ">ECDA</a>) dipped 15.5% to $1.01 in pre-market trading after jumping over 13% on Tuesday.</li>
<li>Zhongchao Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zcmd#NASDAQ">ZCMD</a>) fell 15.4% to $1.82 pre-market trading after jumping around 15% on Tuesday.</li>
<li>reAlpha Tech Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aire#NASDAQ">AIRE</a>) fell 15% to $1.36 in pre-market trading after the company reported EPS for the eight months ended Dec. 31, 2023.</li>
<li>Allbirds, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bird#NASDAQ">BIRD</a>) declined 14% to $0.80 in pre-market trading after the company reported worse-than-expected fourth-quarter GAAP EPS results.</li>
<li>Inspire Veterinary Partners, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ivp#NASDAQ">IVP</a>) shares tumbled 12.1% to $0.0386 in pre-market trading after dipping 20% on Tuesday.</li>
<li>Huize Holding Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/huiz#NASDAQ">HUIZ</a>) shares fell 10.8% to $0.6601 in pre-market trading. Huize Holding is expected to release its fourth quarter and full year 2023 unaudited financial results before the opening bell on March 20, 2024.</li>
<li>Altice USA, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/atus#NYSE">ATUS</a>) shares tumbled 5.6% to $2.51. Altice USA recently announced the appointments of John Hsu, SVP, Corporate Finance and John Lombana, SVP, Corporate Controller.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/03/37641199/dollar-tree-williams-sonoma-and-3-stocks-to-watch-heading-into-wednesday"> Dollar Tree, Williams-Sonoma And 3 Stocks To Watch Heading Into Wednesday</a>

Pre-Market Outlook

AEVA

BHIL

HUIZ

PIXY

TNON

ZCMD

Why SurgePays Shares Are Trading Lower By Around 15%; Here Are 20 Stocks Moving Premarket

Warning: SURG is at high risk of performing badly

Surgepays GAAP EPS of -$0.66, revenue of $15.1M

SurgePays, Inc. (SURG) Q2 2024 Earnings Call Transcript

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Surgepays (NASDAQ:<a href="https://investorplace.com/stock-quotes/surg-stock-quote/">SURG</a>) just reported results for the second quarter of 2024.<ul><li>Surgepays reported earnings per share of -66 cents. This was below the analyst estimate for EPS of -7 cents.</li><li>The company reported revenue of $15.09 million.</li><li>This was 0.42% worse than the analyst estimate for revenue of $15.15 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/surg-stock-earnings-surgepays-for-q2-of-2024/">SURG Stock Earnings: Surgepays Misses EPS, Misses Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

SURG Stock Earnings: Surgepays Misses EPS, Misses Revenue for Q2 2024

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are a hot topic on Wednesday and we have all of the biggest stories traders need to know about this morning!



Moving stocks this morning are earnings reports, a stock offering, a reverse stock split and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Digital Ally (NASDAQ:<a href="https://investorplace.com/stock-quotes/dgly-stock-quote/">DGLY</a>) stock is rocketing more than 107% alongside heavy pre-market trading.</li>



<li>Viracta Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/virx-stock-quote/">VIRX</a>) shares are soaring over 53% with the <a href="https://www.nasdaq.com/press-release/viracta-therapeutics-reports-second-quarter-2024-financial-results-and-provides">release of its Q2 earnings report</a>.</li>



<li>Conduit Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/cdt-stock-quote/">CDT</a>) stock is surging more than 42% on <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318518494&amp;type=PDF&amp;symbol=CDT&amp;cdn=197541151657f71d6ed19abcc1e0e48e&amp;companyName=Conduit+Pharmaceuticals+Inc.&amp;formType=3&amp;formDescription=Initial+statement+of+beneficial+ownership+of+securities&amp;dateFiled=2024-08-13">an investment update</a>.</li>



<li>Nuburu (NYSEMKT:<a href="https://investorplace.com/stock-quotes/buru-stock-quote/">BURU</a>) shares are rising over 26% despite a lack of news this morning.</li>



<li>Jianzhi Education Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/jz-stock-quote/">JZ</a>) stock is gaining close to 19% even with a <a href="https://www.nasdaq.com/press-release/jianzhi-education-technology-group-company-limited-receives-nasdaq-notification-0">recent delisting notice</a>.</li>



<li>Edible Garden (NASDAQ:<a href="https://investorplace.com/stock-quotes/edbl-stock-quote/">EDBL</a>) shares are increasing more than 18% on <a href="https://www.nasdaq.com/press-release/edible-garden-reports-157-increase-gross-profit-fueled-year-over-year-growth-61-cut">strong Q2 earnings</a>.</li>



<li>Ucloudlink (NASDAQ:<a href="https://investorplace.com/stock-quotes/ucl-stock-quote/">UCL</a>) stock is heading over 16% higher with its <a href="https://www.nasdaq.com/press-release/ucloudlink-group-inc-announces-unaudited-second-quarter-2024-financial-results-2024">most recent earnings report</a>.</li>



<li>Vertex Energy (NASDAQ:<a href="https://investorplace.com/stock-quotes/vtnr-stock-quote/">VTNR</a>) shares are jumping 16% with strong early morning trading.</li>



<li>Serve Robotics (NASDAQ:<a href="https://investorplace.com/stock-quotes/serv-stock-quote/">SERV</a>) stock is climbing more than 15% with its <a href="https://www.stocktitan.net/news/SERV/serve-robotics-announces-second-quarter-2024-wqwtqr037uv4.html">Q2 earnings report</a>.</li>



<li>Kamada (NASDAQ:<a href="https://investorplace.com/stock-quotes/kmda-stock-quote/">KMDA</a>) shares are up over 15% after posting <a href="https://www.nasdaq.com/press-release/kamada-reports-strong-second-quarter-and-first-half-2024-financial-results-year-over">positive Q2 earnings results</a>.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>TC BioPharm (NASDAQ:<a href="https://investorplace.com/stock-quotes/tcbp-stock-quote/">TCBP</a>) stock is crashing more than 42% after <a href="https://www.nasdaq.com/press-release/tc-biopharm-announces-pricing-20-registered-direct-offering-2024-08-13">pricing a registered direct offering</a>.</li>



<li>Surgepays (NASDAQ:<a href="https://investorplace.com/stock-quotes/surg-stock-quote/">SURG</a>) shares are plummeting over 26% after <a href="https://www.prnewswire.com/news-releases/surgepays-announces-second-quarter-2024-financial-results-302221503.html">reporting a Q2 loss</a>.</li>



<li>Arcadia Biosciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/rkda-stock-quote/">RKDA</a>) stock is diving more than 16% after <a href="https://markets.businessinsider.com/news/stocks/rkda-stock-earnings-arcadia-biosciences-for-q2-of-2024-1033684150">missing Q2 EPS estimates</a>.</li>



<li>Ouster (NYSE:<a href="https://investorplace.com/stock-quotes/oust-stock-quote/">OUST</a>) shares are taking an over 16% beating on <a href="https://www.businesswire.com/news/home/20240813944318/en/Ouster-Reports-Strong-Revenue-and-Margins-for-Second-Quarter-2024">mixed Q2 earnings</a>.</li>



<li>QuickLogic (NASDAQ:<a href="https://investorplace.com/stock-quotes/quik-stock-quote/">QUIK</a>) stock is tumbling more than 16% with its <a href="https://www.prnewswire.com/news-releases/quicklogic-reports-41-year-over-year-revenue-growth-for-second-quarter-fiscal-2024-302221555.html">latest earnings release</a>.</li>



<li>Brinker International (NYSE:<a href="https://investorplace.com/stock-quotes/eat-stock-quote/">EAT</a>) shares are sliding over 16% after <a href="https://www.investing.com/news/stock-market-news/brinker-international-stock-tumbles-13-on-q4-earnings-miss-93CH-3570960">posting an earnings miss</a>.</li>



<li>Portage Biotech (NASDAQ:<a href="https://investorplace.com/stock-quotes/prtg-stock-quote/">PRTG</a>) stock is falling more than 15% after <a href="https://www.stocktitan.net/news/PRTG/portage-biotech-announces-1-for-20-reverse-stock-sficaewojjpr.html">announcing a reverse stock split</a>.</li>



<li>Global E Online (NASDAQ:<a href="https://investorplace.com/stock-quotes/glbe-stock-quote/">GLBE</a>) shares are decreasing over 14% with its <a href="https://www.stocktitan.net/news/GLBE/global-e-reports-second-quarter-2024-1dq5hcfetvn1.html">Q2 earnings report</a>.</li>



<li>Bionomics (NASDAQ:<a href="https://investorplace.com/stock-quotes/bnox-stock-quote/">BNOX</a>) stock is dropping more than 14% without any clear news this morning.</li>



<li>WISeKey (NASDAQ:<a href="https://investorplace.com/stock-quotes/wkey-stock-quote/">WKEY</a>) shares close out our pre-market stock movers down nearly 14% on a <a href="https://www.nasdaq.com/press-release/sealcoin-secures-50-million-investment-commitment-gem-digital-limited-through-0">new investment</a> <a href="https://www.nasdaq.com/press-release/wisekey-partners-venafi-post-quantum-encryption-services-2024-08-14">and partnership</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/08/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-wednesday-aug-14th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Surgepays&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/surg-stock-quote/">SURG</a>) stock is falling hard on Wednesday after the financial technology and telecom company announced its earnings for the <a href="https://www.prnewswire.com/news-releases/surgepays-announces-second-quarter-2024-financial-results-302221503.html">second quarter of 2024</a>.



The bad news from this earnings report includes the company&rsquo;s diluted EPS of -66 cents. That&rsquo;s nowhere close to the -7 cents per share Wall Street was expecting. It&rsquo;s also significantly worse than then 40 cents per share from the same period of the year prior.



Surgepays&rsquo; revenue of $15.09 million also isn&rsquo;t helping matters today. This is below the $15.15 million in revenue that analysts were expecting. It&rsquo;s also a massive 58% drop year-over-year compared to $35.89 million.



Surgepays&nbsp;chairman and CEO Brian Cox said the following in the earnings report.




&ldquo;The second quarter of 2024 begins a transition phase for SurgePays. ACP funding has run out and there is no guarantee it will return. Fortunately, in the first quarter we shored up our balance sheet and began implementing growth initiatives outside of the ACP program to continue to pursue our strategic goal of being one of the country&rsquo;s largest providers of prepaid wireless and underbanked financial technology services.&rdquo;




<h2>What&rsquo;s Next for SURG Stock?</h2>



Cox notes that the company is currently in a transition phase. This will see it undertake several actions throughout 2024 to improve its fiscal performance. He believes this will result in the company reporting profits again by the end of the year.



SURG stock is down 20.6% as of Wednesday morning.



There are even more stock market stories ready to go today!



We have all of the news that traders need to know about on Wednesday! That includes what&rsquo;s happening with shares of TC BioPharm&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/tcbp-stock-quote/">TCBP</a>) stock, Viracta Therapeutics&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/virx-stock-quote/">VIRX</a>) stock and Digital Ally&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/dgly-stock-quote/">DGLY</a>) stock today. You can catch up on all of these matters at the links below!



<h2>More Stock Market News for Wednesday</h2>



<ul><li><a href="https://investorplace.com/2024/08/why-is-tc-biopharm-tcbp-stock-down-46-today/">Why Is TC BioPharm (TCBP) Stock Down 46% Today?</a></li>



<li><a href="https://investorplace.com/2024/08/why-is-viracta-therapeutics-virx-stock-up-42-today/">Why Is Viracta Therapeutics (VIRX) Stock Up 42% Today?</a></li>



<li><a href="https://investorplace.com/2024/08/why-is-digital-ally-dgly-stock-up-82-today/">Why Is Digital Ally (DGLY) Stock Up 82% Today?</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/08/why-is-surgepays-surg-stock-down-21-today/">Why Is Surgepays (SURG) Stock Down 21% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Surgepays (SURG) Stock Down 21% Today?

In a report released yesterday, Michael Diana from Maxim Group maintained a Hold rating on SurgePays (SURG – Research Report). The company's shares...

Maxim Group Sticks to Their Hold Rating for SurgePays (SURG)

SurgePays starts $5M share buyback program

SurgePays Remains A Wild Card

BNOX

BURU

DGLY

EDBL

GLBE

KMDA

OUST

QUIK

RKDA

SERV

SURGW

TCBP

VIRX

VTNR

WKEY

Press Releases

SurgePays to Participate in Water Tower Fireside Chat Series

SurgePays Announces First Quarter 2024 Earnings Release and Conference Call

SurgePays Announces First Quarter 2024 Financial Results

General

SurgePays, Inc. Announces Launch of Prepaid Wireless Brand LinkUp Mobile

SurgePays Appoints Joseph Gomez as Vice President of MVNO Operations

Fintech

ClearLine to Unveil its Innovative SaaS Retail Point-of-Sale Marketing Solutions at RSPA RetailNOW Conference

SurgePays Announces Second Quarter 2024 Earnings Release and Conference Call

SurgePays Announces Second Quarter 2024 Financial Results

SurgePays Announces Commencement of Share Repurchase Program

SurgePays Announces Master Services Agreement with TerraCom, Inc.

America Movil, S.A.B. de C.V. American Depositary Shares (each representing the right to receive twenty (20) Series B Shares

America Movil

FingerMotion

Gogo

Kore Group Holdings

PLDT

SK Telecom Co

Spok Holdings

Telephone and Data Systems, Inc. Common Shares

Telephone and Data

Millicom International Cellular S.A. - Common Stock

Millicom Intl Cellular

TIM S.A. American Depositary Shares (Each representing 5 Common Shares)

Turkcell Iletisim Hizmetleri AS Common Stock

Turkcell Iletisim

T-Mobile US

uCloudlink Group Inc. - American Depositary Shares

Ucloudlink Group

United States Cellular Corporation Common Stock

United States Cellular

VEON

Vodafone Group Plc - American Depositary Shares each representing ten Ordinary Shares

Vodafone Group

Ascendiant Capital

Comments

Surgepays

Noticias

Últimas noticias sobre Surgepays (NASDAQ:SURG) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL